Drug Discovery Outsourcing Market Forecast 2017-2027
Revenue Prospects for Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening, Leading National Markets and Companies
Drug Discovery Outsourcing – our new study reveals trends, R&D progress, and predicted revenues Where is the Drug Discovery Outsourcing market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead Our 225-page report provides 150 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Drug Discovery Outsourcing market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there forecasts for 4 Drug Discovery Submarkets,
Global Drug Discovery Outsourcing Submarkets • Chemistry Services • Biology Services • Lead Optimisation • Lead Identification and Screening
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 13 leading national markets: • The US • Germany • The UK • Italy • Spain • France • Russia • Japan • South Korea • China • India • Brazil • Mexico
The report also includes profiles and for some of the leading companies in the Drug Discovery Outsourcing market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, India, Brazil and Mexico in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth Overall world revenue for Drug Discovery Outsourcing will surpass $21bn in 2017, our work calculates. We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Drug Discovery Outsourcing Market report helps you In summary, our 225-page report provides you with the following knowledge: • Revenue forecasts to 2027 for the Drug Discovery Outsourcing market, with forecasts for 4 submarkets, each forecasted at a global level – discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2027 for 13 key national markets – See forecasts for the Drug Discovery Outsourcing market in the US, Mexico, Brazil, Germany, France, the UK, Italy, Spain, Russia, China, India, Japan, and South Korea • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Drug Discovery Outsourcing market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Outsourcing market and leading companies. You will find data, trends and predictions.
Get our report today Drug Discovery Outsourcing Market Analysis : Revenue Prospects for Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening, Leading National Markets and Companies.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview
1.1 The Drug Discovery Outsourcing Market Overview
1.2 Drug Discovery Outsourcing Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. An Introduction to Drug Discovery Outsourcing
2.1 What is Outsourcing?
2.2 What is Drug Discovery Outsourcing?
2.3 Why Outsource Drug Discovery?
2.4 A Common Drug Discovery Model Includes Pharmaceutical Organizations Collaborating with Academia
2.5 The Outsource Model for Drug Development Increases Innovation
2.6 Outsourced Processes in Drug Discovery
2.7 Challenges with Drug Discovery Outsourcing
2.8 Emerging Markets are a Popular Destination for CROs
2.9 Strategic Partnerships to Acquisitions
2.10 Recent Drug Development Outsourcing Agreements
3. Global Drug Discovery Outsourcing Market and Service Area Submarkets, 2017-2027
3.1 Drug Discovery Outsourcing: Global Market Overview
3.2 The Global Drug Discovery Outsourcing Market Sectors
3.3 The Global Drug Discovery Outsourcing Market by Sector, 2016
3.4 The Global Drug Discovery Outsourcing Market by Sector, 2016-2027
3.5 The Changing Market Shares by Sector, 2016-2027
3.6 The Global Chemistry Services Outsourcing Market, 2016
3.6.1 Libraries
3.6.2 Building Blocks
3.6.3 Compound Synthesis
3.6.4 The Global Chemistry Services Outsourcing Market Forecast, 2016-2027
3.7 The Global Biology Services Outsourcing Market, 2016
3.7.1 Target Identification
3.7.2 Target Validation
3.7.3 The Global Biology Services Outsourcing Market Forecast, 2016-2027
3.8 The Global Lead Optimisation Market, 2016
3.8.1 ADMET Screening: Prevents Late Stage Failure of Clinical Trials
3.8.2 The Global Lead Optimisation Market Forecast, 2016-2027
3.9 The Global Lead Identification and Screening Outsourcing Market, 2016
3.9.1 Methods of Screening in Drug Discovery
3.9.2 Primary Screening
3.9.3 The Global Lead Identification and Screening Outsourcing Market Forecast, 2016-2027
4. The Leading National Markets in the Drug Discovery Outsourcing Market 2016-2027
4.1 Drug Discovery Outsourcing Overview
4.2 The Leading National Markets in the Drug Discovery Outsourcing Market, 2016
4.3 The Leading National Markets in the Drug Discovery Outsourcing Market, 2016-2027
4.4 The Changing Market Shares of the Leading National Markets in the Drug Discovery Outsourcing Market, 2016-2027
4.5 CAGRs of the Leading National Markets in the Drug Discovery Outsourcing Market, 2016-2027
4.6 The US Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
4.7 The EU5 Drug Discovery Outsourcing Market by Region, 2016
4.7.1 The EU5 Drug Discovery Outsourcing Market Forecast, 2016-2027
4.7.2 CAGRs by EU5 Region, 2016-2027
4.7.3 The EU5 Changing Market Shares by Country 2017-2027
4.7.3.1 The German Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
4.7.3.2 The UK Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
4.7.3.3 The French Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
4.7.3.4 The Italian Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
4.7.3.5 The Spanish Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
4.8 The Japanese Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
4.9 The Chinese Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
4.9.1 Challenges to China’s Growth
4.10 The Indian Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
4.11 The Brazilian Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
4.12 The Russian Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
4.13 The South Korean Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
4.14 The Mexican Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
4.15 The Rest of the World Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
5. Leading Companies in the Drug Discovery Outsourcing Market
5.1 Drug Discovery Outsourcing: A Fragmented and Growing Marketplace
5.2 Characteristics of Leading Contract Research Organisations
5.2.1 A Highly Quality Workforce
5.2.2 Emphasis on Intellectual Property Protection
5.2.3 Long Term Working Relationship
5.2.4 Success in Project Completion
5.2.5 Internal Drug Discovery Programmes
5.3 Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market
5.4 Albany Molecular Research (AMRI)
5.4.1 Historical Sales and Recent Financial Performance, 2013-2016
5.4.2 AMRI’s Drug Discovery Services
5.4.3 Internal Portfolio of Drug Discovery and Development Programme Collaborations
5.4.4 AMRI (DDS) Sales Forecast, 2016-2027
5.5 Aptuit
5.5.1 INDIGO: Accelerating Early Drug Candidates
5.5.2 Aptuit Clinical Trial Supplies
5.5.3 Strategic Partnerships, Acquisitions and Divestitures
5.5.3.1 Divestiture of Aseptic Clinical Manufacturing
5.5.3.2 Aptuit’s Extended Partnership with GSK for Verona Centre
5.5.3.3 Partnership with Siena Biotech
5.5.3.4 Partnership with Laurus Labs
5.5.3.5 Partnership with Regulus Therapeutics Inc.
5.5.3.6 Partnership with Chronos Therapeutics
5.5.3.7 Partnership with Chiesi Farmaceutici
5.5.3.8 Partnership with SAMDI Tech, Inc.
5.6 Charles River Laboratories
5.6.1 Historical Sales and Financial Performance, 2013-2016
5.6.2 Charles River Laboratories: An External Acquisition Strategy
5.6.2.1 Acquisition of ChanTest
5.6.2.2 Acquisition of Galapagos’ CRO Services Division (BioFocus and Argenta)
5.6.2.3 Acquisition of VivoPath
5.6.2.4 Partnership with Chiesi Farmaceutici SpA
5.6.2.5 Partnership with Nimbus Therapeutics
5.6.3 Charles River Laboratories: Revenue and Financial Analysis, 2016
5.6.3.1 Charles River Laboratories: Historical Financial Performance by Business Segment, 2014-2016
5.6.4 Charles River Laboratories Sales Forecast, 2016-2027
5.7 Covance (Acquired by Laboratory Corporation of America)
5.7.1 Covance: Historical Revenue and Financial Performance, 2010-2013
5.7.2 Covance: Early Stage Discovery Efforts
5.7.3 Agreement with Sanofi
5.7.4 Agreement with Kellogg Company
5.7.5 Agreement with Bio Pontis Alliance
5.7.6 Agreement with Indiana Clinical and Translational Sciences Institute (CTSI)
5.7.7 Agreement with Eli Lilly
5.8 Cyprotex
5.8.1 Historical Revenue and Financial Performance, 2011-2014
5.8.2 Cyprotex: Revenue by Region, 2015
5.9 Domainex
5.9.1 Drug Pipeline
5.9.2 TBK1/ IKKε-Inhibitors
5.9.3 Methyltransferase (KMTS) Inhibitors
5.10 Evotec
5.10.1 Strategic Action Plan
5.10.2 Evotec: Historical Revenue and Financial Analysis, 2013-2016
5.10.3 EVT Integrate and EVT Innovate
5.10.4 Partnerships with Pharma for Drug Discovery
5.10.4.1 Partnership with Sanofi
5.10.4.2 Extended Partnership with Evotec
5.10.4.3 Partnership with Johnson & Johnson
5.10.4.4 Partnership with AstraZeneca
5.10.4.5 Partnership with Bayer Pharmaceuticals
5.10.4.6 Partnership with Boehringer Ingelheim Pharma
5.10.4.7 Collaboration with CHDI
5.10.4.8 Collaboration with Janssen
5.10.4.9 Collaboration with MedImmune
5.10.4.10 Collaboration with UCB Pharma
5.10.5 Evotec Sales Forecast, 2015-2026
5.11 GenScript
5.11.1 GenScript: Agreements and Partnerships
5.12 Pharmaceutical Product Development (PPD)
5.12.1 PPD: Agreements, Strategic Partnerships and Private Merger
5.12.1.1 Acquisition of Acurian
5.12.1.2 Partnership with Elan
5.12.1.3 Partnership with GSK
5.13 QuintilesIMS
5.13.1 QuintilesIMS: Historical Revenue and Financial Performance, 2013-2016
5.13.2 Development Deal With Merck
5.13.3 QuintilesIMS: Acquisition of Advion Bioanalytical Labs
5.13.4 QuintilesIMS: Shedding Jobs
5.13.5 Merger with IMS
5.13.5 QuintilesIMS Sales Forecast, 2016-2027
5.14 Selcia
5.14.1 A Strong Natural Product Chemistry Track Record
5.14.3 Collaboration with Cantab
5.15 Viva Biotech
5.15.1 GPCR Targeted Discovery Programs
5.15.2 Antibody Therapeutics Discovery
5.16 WIL Research Laboratories
5.16.1 Focus on Preclinical Research
5.16.2 Acquisition of Ricerca Biosciences LLC
5.16.3 Acquisition of Midwest Bio Research
5.17 WuXi Apptec
5.17.1 WuXi AppTec: Service Offerings
5.17.2 Acquisition of Next CODE Health
5.17.3 WuXiAppTec: Historical Revenue and Financial Performance, 2010-2014
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
